North America Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), By Distribution Channel, By Country and Growth Forecast, 202

North America Polyacrylamide Market Size, Share & Industry Trends Analysis Report By Product (Anionic, Cationic, and Non-ionic), By Application (Water Treatment, Oil & Gas, Paper Making), By Country and Growth Forecast, 2023 - 2030


The North America Polyacrylamide Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 479.5 Kilo Tonnes, showcasing a growth of 4.8% (2019-2022).

The oil and gas industry's continuous quest to maximize oil recovery from reservoirs has driven the adoption of polyacrylamide-based EOR techniques. This is particularly relevant as mature oil fields require advanced recovery methods. The growing demand for paper products and the need for resource-efficient production processes have led to the widespread use of polyacrylamide in the paper and pulp sectors.

In addition, the mining industry, which faces challenges related to water management and environmental impact, has embraced polyacrylamide to improve mineral processing and reduce ecological consequences. Increasing urbanization and infrastructure development projects have heightened the demand for polyacrylamide in construction activities to stabilize soil and mitigate erosion risks.

There is a growing trend toward developing and adopting bio-based polyacrylamides, which are considered more environmentally friendly and sustainable than their synthetic counterparts. Integrating digital technologies and data analytics in water management is becoming more prevalent. Polyacrylamides are used with smart water management systems to optimize water treatment processes.

Moreover, Canada's urban centers have been growing due to population influx and migration. This growth has increased demand for residential, commercial, and infrastructure construction to accommodate the expanding urban populations. Both federal and provincial governments in Canada have been investing in large-scale infrastructure projects, including highways, bridges, public transit systems, airports, and municipal utilities. These investments aim to improve transportation, connectivity, and public services.

According to Statistics Canada, investment in non-residential construction was up slightly, increasing 0.5% to $5.9 billion in July 2023. Investment in the industrial component increased 0.6% to $1.2 billion, while commercial investment edged up 0.3% to $3.3 billion. Institutional construction investment rose by 1.2% to $1.5 billion. Polyacrylamide's versatility and ability to modify the properties of soil, water, and construction materials make it a valuable additive in various construction applications. These factors will help in driving the expansion of the market in the North America region.

The US market dominated the North America Polyacrylamide Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,259.7 Million by 2030. The Canada market is exhibiting a CAGR of 8.6% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 7.7% during (2023 - 2030).

Based on Product, the market is segmented into Anionic, Cationic, and Non-ionic. Based on Application, the market is segmented into Water Treatment, Oil & Gas, Paper Making, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Anhui Jucheng Fine Chemicals Co., LTD, Ashland, Inc., BASF SE, Kemira Oyj, SNF Group, Black Rose Industries Ltd., Shandong Baomo Biochemical Co., Ltd., Xitao Polymer Co., Ltd., The Dow Chemical Company (Dow Corning Ltd.), and Solvay SA.

Scope of the Study

Market Segments covered in the Report:

By Product (Volume, Kilo Tonnes, USD Million, 2019-2030)
  • Anionic
  • Cationic
  • Non-ionic
By Application (Volume, Kilo Tonnes, USD Million, 2019-2030)
  • Water Treatment
  • Oil & Gas
  • Paper Making
  • Others
By Country (Volume, Kilo Tonnes, USD Million, 2019-2030)
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Anhui Jucheng Fine Chemicals Co., LTD
  • Ashland, Inc.
  • BASF SE
  • Kemira Oyj
  • SNF Group
  • Black Rose Industries Ltd.
  • Shandong Baomo Biochemical Co., Ltd.
  • Xitao Polymer Co., Ltd.
  • The Dow Chemical Company (Dow Corning Ltd.)
  • Solvay SA
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pigmentation Disorder Treatment Market, by Type
1.4.2 North America Pigmentation Disorder Treatment Market, by Treatment
1.4.3 North America Pigmentation Disorder Treatment Market, by Distribution Channel
1.4.4 North America Pigmentation Disorder Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. North America Pigmentation Disorder Treatment Market, By Type
4.1 North America Vitiligo Market, By Country
4.2 North America Melasma Market, By Country
4.3 North America Others Market, By Country
Chapter 5. North America Pigmentation Disorder Treatment Market, By Treatment
5.1 North America Corticosteroids Market, By Country
5.2 North America Calcineurin Inhibitor Market, By Country
5.3 North America Others Market, By Country
Chapter 6. North America Pigmentation Disorder Treatment Market, By Distribution Channel
6.1 North America Drug Store & Retail Pharmacies Market, By Country
6.2 North America Hospital Pharmacies Market, By Country
6.3 North America Online Pharmacies Market, By Country
Chapter 7. North America Pigmentation Disorder Treatment Market, By Country
7.1 US Pigmentation Disorder Treatment Market
7.1.1 US Pigmentation Disorder Treatment Market, By Type
7.1.2 US Pigmentation Disorder Treatment Market, By Treatment
7.1.3 US Pigmentation Disorder Treatment Market, By Distribution Channel
7.2 Canada Pigmentation Disorder Treatment Market
7.2.1 Canada Pigmentation Disorder Treatment Market, By Type
7.2.2 Canada Pigmentation Disorder Treatment Market, By Treatment
7.2.3 Canada Pigmentation Disorder Treatment Market, By Distribution Channel
7.3 Mexico Pigmentation Disorder Treatment Market
7.3.1 Mexico Pigmentation Disorder Treatment Market, By Type
7.3.2 Mexico Pigmentation Disorder Treatment Market, By Treatment
7.3.3 Mexico Pigmentation Disorder Treatment Market, By Distribution Channel
7.4 Rest of North America Pigmentation Disorder Treatment Market
7.4.1 Rest of North America Pigmentation Disorder Treatment Market, By Type
7.4.2 Rest of North America Pigmentation Disorder Treatment Market, By Treatment
7.4.3 Rest of North America Pigmentation Disorder Treatment Market, By Distribution Channel
Chapter 8. Company Profiles
8.1 Bausch Health Companies Inc
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Obagi Cosmeceuticals LLC
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 AbbVie, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 SWOT Analysis
8.6 Incyte Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.3.1 Acquisition and Mergers:
8.6.3.2 Trials and Approvals:
8.6.4 SWOT Analysis
8.7 Dr. Reddy’s Laboratories Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Galderma S.A.
8.8.1 Company Overview
8.9 Viatris, Inc. (Mylan N.V.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings